Pathos AI is a clinical-stage biotechnology company that leverages advanced artificial intelligence (AI) technologies to revolutionize drug development, particularly in the field of oncology. Central to their approach is the PathOS Platform™, which utilizes extensive real-world oncology data and patient-derived functional genomic data to uncover biological insights that traditional methods may overlook. This platform enables Pathos to optimize patient selection strategies, ensuring that clinical-stage therapeutics are developed for patients who are most likely to benefit from them. By focusing on biomarker-driven development paths, Pathos aims to accelerate the approval process for highly efficacious drugs, ultimately improving patient outcomes.

The company is also pioneering a self-learning therapeutics engine that automates target identification and prioritization through a combination of in silico analyses and biological modeling. This engine is designed to harmonize data from various sources, creating a robust machine learning framework that enhances predictive capabilities throughout the drug development process. By integrating multimodal datasets and continuously refining their hypotheses based on real-world patient data, Pathos AI is positioned to transform each step of drug development—from trial design to clinical operations—thereby expediting the delivery of precision medicines to patients in need.

United States

Pathos was borne from the belief that cancer is a collection of hundreds of rare diseases and can be best described by pathways accounting for the pathophysiology of patients. We license or co-develop clinical-stage therapeutics to ensure highly efficacious drugs are developed for the patients most likely to benefit and with significant unmet needs.

Our patient selection strategies are optimized for the fastest path to approval to improve patient outcomes as quickly as possible. Our aim is ultimately to accelerate the translation of real-world data into breakthrough therapies for patients that need them most.

Pathos AI

Company Details